Tesamorelin 20mg

Tesamorelin 20mg — Research Peptide

Tesamorelin (CAS 218949-48-5) is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH). FDA-approved as Egrifta for HIV-associated lipodystrophy, tesamorelin has extensive clinical trial data demonstrating significant reductions in visceral adipose tissue and improvements in GH/IGF-1 axis activity. Research-grade 20mg vial at ≥99% purity. For research purposes only.